Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Pharma
With strong data, Lilly plots filings for weekly insulin asset
With detailed readouts from a suite of late-stage trials, Eli Lilly is heading to regulators with its once-a-week insulin asset efsitora alfa.
Fraiser Kansteiner
Jun 23, 2025 10:16am
Lilly, Novo will be pharma sales leaders by 2030, Evaluate says
Jun 23, 2025 9:52am
ExCellThera's novel blood cancer cell therapy gains CHMP nod
Jun 20, 2025 11:55am
Trump rekindles pharmaceutical tariff threat: Reuters
Jun 17, 2025 11:21am
Lilly fills out lineup of Zepbound doses on self-pay website
Jun 16, 2025 11:48am
The 10 highest-paid Big Pharma CEOs of 2024
Jun 16, 2025 3:00am
